Akso Health Group (AHG)
0.77
-0.07
(-8.34%)
USD |
NASDAQ |
Apr 24, 16:00
Akso Health Group Total Assets (Quarterly): 16.88M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 16.88M |
| September 30, 2023 | 16.88M |
| March 31, 2023 | 20.46M |
| September 30, 2022 | 20.91M |
| September 30, 2022 | 20.91M |
| March 31, 2022 | 62.81M |
| September 30, 2021 | 32.52M |
| March 31, 2021 | 31.69M |
| September 30, 2020 | 60.18M |
| September 30, 2019 | 133.32M |
| Date | Value |
|---|---|
| June 30, 2019 | 146.79M |
| March 31, 2019 | 173.26M |
| December 31, 2018 | 137.53M |
| September 30, 2018 | 150.21M |
| June 30, 2018 | 189.99M |
| March 31, 2018 | 163.89M |
| December 31, 2017 | 144.84M |
| September 30, 2017 | 61.68M |
| June 30, 2017 | 39.96M |
| March 31, 2017 | 28.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
16.88M
Minimum
Sep 2023
146.79M
Maximum
Jun 2019
51.21M
Average
31.69M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| Universe Pharmaceuticals Inc | 53.29M |
| Sinovac Biotech Ltd | 13.73B |
| CASI Pharmaceuticals Inc | 75.27M |
| Zai Lab Ltd | 1.036B |
| I-MAB | 484.12M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.55M |
| Shareholders Equity (Quarterly) | 5.223M |
| Debt to Equity Ratio | 0.067 |
| Current Ratio | 1.462 |
| Net Debt Paydown Yield | -0.49% |